Share-Based Payment (Tables)

12 Months Ended

Dec. 31, 2019

Share-Based Payment [Abstract]

Schedule of expense recognized in the financial statements for services

	Year ended December 31,
	2019		2018		2017
Equity-settled share-based payment plans to employees, directors and consultants	$	1,263	$	710	$	1,028

Schedule of share-based payment transactions granted to its employees, directors and consultants

Issuance Date	Grantee	Options outstanding as of December 31, 2019		Exercise price NIS		Exercise price $*)		Exercisable as of December 31, 2019		Exercisable Through	Total Fair Value $
December 8, 2015	Employees and Consultant		292,250		25.99		6.70		292,250	December 8, 2025		1,053
December 8, 2015	Employees and Consultant		270,000		31.19		8.04		270,000	December 8, 2025		1,247
April 1, 2017	Chief Executive Officer and Director		566,262		19.97		5.47		566,262	April 1, 2025		1,100
December 3, 2017	Director		27,500		21.37		6.12		9,167	December 3, 2027		54
November 12, 2018	Directors		110,000		23.39		6.36		—	November 12, 2026		298
November 12, 2018	Employees and officers		672,600		23.39 - 24.22		6.36 - 6.59		—	November 12, 2026		2,299
October 1, 2019	Chief Financial and Operating Officer		50,000		19.08		5.48		—	October 1, 2027		100

*) As of grant date.

Schedule of fair value of options granted

	Year ended December 31,
	2019		2018		2017
Dividend yield (%)		0		0		0
Expected volatility (%)		40.06 - 48.09		40.51 - 48.25		40.58 - 56.77
Risk-free interest rate (%)		1.61 – 1.73		0.28 - 2.22		0.11 - 2.00
Expected exercise factor		2.8		2.8		2.8
Post-vesting forfeiture rate (%)		5		5		5 - 10

Schedule of share-based payment movement during the year

	Year ended December 31,
	2019					2018
	Number of options			Weighted average exercise price(*)		Number of options			Weighted average exercise price(*)
				$					$
Outstanding at January 1,		2,425,192		$	6.6		1,721,059		$	7.9
Granted		50,000			5.5		962,300			6.3
Expired		(59,765	)		7.5		(199,499	)		10.8
Forfeited		(201,615	)		7.0		(58,668	)		7.9
Outstanding at December 31,		2,213,812		$	7.1		2,425,192		$	6.6
Exercisable at December 31,		1,362,879		$	7.38		912,893		$	7.17

(*) The exercise price of all options denominated in NIS and was translated to USD in the table above using the exchange rate as of December 31, 2019 and 2018, respectively.